Ardelyx | ARDX - Interest Expense On Debt

Stock Price
6.23
Daily Change
-0.23 -3.56%
Monthly
-0.80%
Yearly
60.57%
Q2 Forecast
6.64

Ardelyx reported $5.76M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Amgen USD 657M 4M Mar/2026
Ardelyx USD 5.76M 37K Dec/2025
aTyr Pharma 79.65M 78.89M Mar/2026
Corcept Therapeutics USD 814.88M 809.46M Mar/2026
Curis USD 178K 441K Dec/2023
Sanofi EUR -25M 99.78M Dec/2025
TG Therapeutics USD 7.67M 1.13M Mar/2026
United Therapeutics USD 3.1M 100K Dec/2025
Xoma USD 3.4M 150K Jun/2024